EE232 Cost-Effectiveness of a Genomic Profiling Test for HRD Determination in Ovarian Cancer Into the Current Clinical Practice for Platinum-Sensitive Patients With Advanced Ovarian Cancer in Greece

Dec 1, 2023, 00:00 AM
10.1016/j.jval.2023.09.500
https://www.valueinhealthjournal.com/article/S1098-3015(23)03630-6/fulltext
Section Title :
Section Order : 12523
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03630-6&doi=10.1016/j.jval.2023.09.500
HEOR Topics :
Tags :
Regions :